DAFNA Capital Management as of Dec. 31, 2024
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 82 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p Biotech Etf Etf (XBI) | 9.1 | $36M | 398k | 90.06 | |
| Stereotaxis Com New (STXS) | 7.9 | $31M | 14M | 2.28 | |
| Revolution Medicines (RVMD) | 7.0 | $28M | 631k | 43.74 | |
| AtriCure (ATRC) | 5.0 | $20M | 642k | 30.56 | |
| Merus N V (MRUS) | 4.8 | $19M | 452k | 42.05 | |
| Cytokinetics Com New (CYTK) | 4.8 | $19M | 398k | 47.04 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 3.6 | $14M | 103k | 137.67 | |
| Axogen (AXGN) | 3.5 | $14M | 847k | 16.48 | |
| Ishares Nasdaq Biotech Indx Etf (IBB) | 3.4 | $14M | 103k | 132.21 | |
| Blueprint Medicines (BPMC) | 3.3 | $13M | 150k | 87.22 | |
| Ideaya Biosciences (IDYA) | 3.3 | $13M | 499k | 25.70 | |
| Xenon Pharmaceuticals (XENE) | 2.7 | $11M | 274k | 39.20 | |
| Neurocrine Biosciences (NBIX) | 2.5 | $9.8M | 72k | 136.50 | |
| Day One Biopharmaceuticals I (DAWN) | 2.4 | $9.3M | 731k | 12.67 | |
| Biohaven (BHVN) | 2.1 | $8.2M | 220k | 37.35 | |
| Tandem Diabetes Care Com New (TNDM) | 2.0 | $8.0M | 223k | 36.02 | |
| Syndax Pharmaceuticals (SNDX) | 1.8 | $7.2M | 542k | 13.22 | |
| Kalvista Pharmaceuticals (KALV) | 1.7 | $6.9M | 812k | 8.47 | |
| Urogen Pharma (URGN) | 1.3 | $5.2M | 493k | 10.65 | |
| Dex (DXCM) | 1.3 | $5.1M | 66k | 77.77 | |
| BioCryst Pharmaceuticals (BCRX) | 1.3 | $5.0M | 667k | 7.52 | |
| Edgewise Therapeutics (EWTX) | 1.3 | $5.0M | 187k | 26.70 | |
| Ascendis Pharma A/s Note 2.250% 4/0 (Principal) | 1.1 | $4.4M | 4.0M | 1.10 | |
| Tela Bio (TELA) | 1.1 | $4.4M | 1.4M | 3.02 | |
| Proqr Therapeutics N V Shs Euro (PRQR) | 1.1 | $4.2M | 1.6M | 2.65 | |
| Kura Oncology (KURA) | 1.0 | $3.9M | 448k | 8.71 | |
| Arcus Biosciences Incorporated (RCUS) | 1.0 | $3.8M | 254k | 14.89 | |
| Galapagos Nv Spon Adr (GLPG) | 0.9 | $3.6M | 130k | 27.50 | |
| Alkermes SHS (ALKS) | 0.9 | $3.5M | 121k | 28.76 | |
| Insulet Corporation (PODD) | 0.8 | $3.2M | 12k | 261.07 | |
| Astria Therapeutics (ATXS) | 0.7 | $2.7M | 300k | 8.94 | |
| Immunovant (IMVT) | 0.7 | $2.7M | 108k | 24.77 | |
| Allogene Therapeutics (ALLO) | 0.7 | $2.6M | 1.2M | 2.13 | |
| Viking Therapeutics (VKTX) | 0.7 | $2.6M | 65k | 40.24 | |
| Lexeo Therapeutics (LXEO) | 0.7 | $2.6M | 393k | 6.58 | |
| Accuray Incorporated (ARAY) | 0.6 | $2.4M | 1.2M | 1.98 | |
| Keros Therapeutics (KROS) | 0.5 | $2.1M | 130k | 15.83 | |
| Inogen (INGN) | 0.5 | $1.9M | 209k | 9.17 | |
| Stoke Therapeutics (STOK) | 0.5 | $1.9M | 171k | 11.03 | |
| Bicara Therapeutics (BCAX) | 0.5 | $1.8M | 106k | 17.42 | |
| Brainsway Sponsored Ads (BWAY) | 0.5 | $1.8M | 193k | 9.43 | |
| Mineralys Therapeutics (MLYS) | 0.5 | $1.8M | 147k | 12.31 | |
| Immatics Nv SHS (IMTX) | 0.4 | $1.7M | 245k | 7.11 | |
| Alector (ALEC) | 0.4 | $1.7M | 913k | 1.89 | |
| Century Therapeutics (IPSC) | 0.4 | $1.7M | 1.7M | 1.01 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.4 | $1.7M | 121k | 14.00 | |
| Iteos Therapeutics | 0.4 | $1.4M | 188k | 7.68 | |
| Larimar Therapeutics (LRMR) | 0.4 | $1.4M | 371k | 3.87 | |
| Regulus Therapeutics | 0.4 | $1.4M | 875k | 1.58 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.4 | $1.4M | 587k | 2.35 | |
| Gossamer Bio (GOSS) | 0.3 | $1.3M | 1.4M | 0.90 | |
| 2seventy Bio Common Stock | 0.3 | $1.3M | 429k | 2.94 | |
| Lineage Cell Therapeutics In (LCTX) | 0.3 | $1.3M | 2.5M | 0.50 | |
| Neurogene (NGNE) | 0.3 | $1.2M | 52k | 22.86 | |
| Mediwound Shs New (MDWD) | 0.3 | $1.1M | 65k | 17.80 | |
| Align Technology (ALGN) | 0.3 | $1.1M | 5.5k | 208.51 | |
| Biontech Se Sponsored Ads (BNTX) | 0.2 | $969k | 8.5k | 113.95 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.2 | $963k | 36k | 27.12 | |
| Silverback Therapeutics (SPRY) | 0.2 | $937k | 89k | 10.55 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.2 | $919k | 243k | 3.78 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.2 | $904k | 523k | 1.73 | |
| Polypid (PYPD) | 0.2 | $886k | 291k | 3.04 | |
| Foghorn Therapeutics (FHTX) | 0.2 | $881k | 187k | 4.72 | |
| Palvella Therapeutics Inc Ne (PVLA) | 0.2 | $857k | 72k | 12.00 | |
| Sutro Biopharma (STRO) | 0.2 | $804k | 437k | 1.84 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.2 | $795k | 48k | 16.75 | |
| Vir Biotechnology (VIR) | 0.2 | $734k | 100k | 7.34 | |
| Compugen Ord (CGEN) | 0.2 | $684k | 447k | 1.53 | |
| Acrivon Therapeutics Common Stock (ACRV) | 0.2 | $677k | 112k | 6.02 | |
| Sage Therapeutics (SAGE) | 0.1 | $588k | 108k | 5.43 | |
| Adicet Bio (ACET) | 0.1 | $577k | 600k | 0.96 | |
| Masimo Corporation (MASI) | 0.1 | $496k | 3.0k | 165.30 | |
| Aquestive Therapeutics (AQST) | 0.1 | $452k | 127k | 3.56 | |
| Aprea Therapeutics Com New (APRE) | 0.1 | $451k | 137k | 3.29 | |
| Adc Therapeutics Sa SHS (ADCT) | 0.1 | $446k | 224k | 1.99 | |
| Perspective Therapeutics Com New (CATX) | 0.1 | $415k | 130k | 3.19 | |
| Black Diamond Therapeutics (BDTX) | 0.1 | $300k | 140k | 2.14 | |
| Biomx Com New (PHGE) | 0.1 | $293k | 401k | 0.73 | |
| Acelyrin | 0.1 | $276k | 88k | 3.14 | |
| Compass Therapeutics (CMPX) | 0.1 | $230k | 158k | 1.45 | |
| Nevro (NVRO) | 0.0 | $141k | 38k | 3.72 | |
| Spero Therapeutics (SPRO) | 0.0 | $129k | 125k | 1.03 |
